Mergers & Acquisitions, Financing, Equity Capital Markets

Orchestra BioMed, Inc.

01/23
|
$180.0 Million
orchestrabio
healthsciences
Piper Sandler served as capital markets advsior for Orchestra BioMed, Inc. on business combination with Health Sciences Acquisitions Corporation 2; joint lead placement agent on a Series D financing; and financial advisor on the strategic collaboration with Medtronic
Sub-Type
Advisory
Sub-Sector
Med-Tech